Eric Topol, Founder and Director of Scripps Research Translational Institute at The Scripps Research Institute, shared two recent articles on LinkedIn:
“Best evidence yet that GLP-1 drugs reduce the risk of substance abuse, from >600,000 US Veterans with diabetes across alcohol, nicotine, opioid, cocaine, cannabis.”
Other articles featuring Eric Topol on OncoDaily.